Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|September 14, 2012
8-Amino-adenosine activates p53-independent cell death of metastatic breast cancersAlla Polotskaia, Sandy Hoffman, Nancy L Krett, et al.
Plos One|October 23, 2013
Endogenous human MDM2-C is highly expressed in human cancers and functions as a p53-independent growth activatorDanielle R Okoro, Nicoleta Arva, Chong Gao, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2015
Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4Alla Polotskaia, Gu Xiao, Katherine Reynoso, et al.
Frontiers in Cell and Developmental Biology|December 9, 2021
Oligomerization of Mutant p53 R273H is not Required for Gain-of-Function Chromatin Associated ActivitiesGeorge K Annor, Nour Elshabassy, Devon Lundine, et al.
Ethnicity & Disease|July 23, 2008
Disruption of the p53-Mdm2 complex by Nutlin-3 reveals different cancer cell phenotypesNicoleta C Arva, Kathryn E Talbott, Danielle R Okoro, et al.
Breast Cancer Research and Treatment|November 25, 2018
MDM2, MDM2-C, and mutant p53 expression influence breast cancer survival in a multiethnic populationLenora W M Loo, Chong Gao, Yurii B Shvetsov, et al.
The Journal of Biological Chemistry|August 17, 2002
Differential activation of p53 by the various adducts of mitomycin CTarek Abbas, Magali Olivier, Jaqueline Lopez, et al.
Molecular Cancer Research : MCR|September 8, 2022
The C-terminus of Gain-of-Function Mutant p53 R273H Is Required for Association with PARP1 and Poly-ADP-RiboseDevon Lundine, George K Annor, Valery Chavez, et al.
Pageof 5